Prenatal dioxin exposure and thyroid hormone levels in the Seveso second generation study.
Dioxins
Prenatal exposure
Seveso
TCDD
Thyroid hormones
Journal
Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
07
01
2020
revised:
14
02
2020
accepted:
19
02
2020
entrez:
22
4
2020
pubmed:
22
4
2020
medline:
12
9
2020
Statut:
ppublish
Résumé
In animal studies, perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters thyroid homoeostasis and thyroid hormone concentrations; epidemiologic evidence is limited. We aimed to determine the association of prenatal exposure to TCDD with thyroid hormone concentrations in the Seveso Second Generation Study, a unique cohort of children born to TCDD-exposed women resulting from a 1976 chemical factory explosion in Seveso, Italy. We included 570 children (288 female, 282 male) with complete follow-up data, including a fasting blood draw. Serum levels of total and free thyroxine (T4), free triiodothyronine (T3), and thyroid stimulating hormone (TSH) were measured using immunoassays. We defined prenatal TCDD exposure as: 1) maternal initial TCDD concentration measured in serum collected soon after the explosion and 2) maternal TCDD estimated at pregnancy. Compared to the lowest quartile (Q1), maternal initial serum TCDD was associated with lower free T3 (Q2: adj-β = -0.13, 95%CI -0.26, 0.00; Q3: adj-β = -0.22, 95%CI -0.35, -0.09; Q4: adj-β = -0.14, 95%CI -0.28, 0.00; p-trend = 0.02). In participants with high thyroid antibody status, inverse associations between maternal initial serum TCDD and free T3 were significantly stronger than in participants with normal antibody status (p-interaction = 0.02). We also observed a positive association between maternal initial serum TCDD and TSH concentrations in participants with high thyroid antibody status (Q2: adj-β = 11.4%, 95%CI -25.2, 66.1; Q3: adj-β = 49.0%, 95%CI 3.0, 115.5; Q4: adj-β = 105.5, 95%CI 36.6, 209.2; p-trend < 0.01) but not in those participants with normal antibody status (p-interaction < 0.01). Similar results were found for TCDD estimated at pregnancy. Our results suggest prenatal exposure to TCDD, a potent endocrine-disrupting compound, may alter thyroid function later in life. Populations with additional thyroid stress may be particularly susceptible to in utero exposure of thyroid disrupting chemicals.
Sections du résumé
BACKGROUND
In animal studies, perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters thyroid homoeostasis and thyroid hormone concentrations; epidemiologic evidence is limited.
OBJECTIVES
We aimed to determine the association of prenatal exposure to TCDD with thyroid hormone concentrations in the Seveso Second Generation Study, a unique cohort of children born to TCDD-exposed women resulting from a 1976 chemical factory explosion in Seveso, Italy.
METHODS
We included 570 children (288 female, 282 male) with complete follow-up data, including a fasting blood draw. Serum levels of total and free thyroxine (T4), free triiodothyronine (T3), and thyroid stimulating hormone (TSH) were measured using immunoassays. We defined prenatal TCDD exposure as: 1) maternal initial TCDD concentration measured in serum collected soon after the explosion and 2) maternal TCDD estimated at pregnancy.
RESULTS
Compared to the lowest quartile (Q1), maternal initial serum TCDD was associated with lower free T3 (Q2: adj-β = -0.13, 95%CI -0.26, 0.00; Q3: adj-β = -0.22, 95%CI -0.35, -0.09; Q4: adj-β = -0.14, 95%CI -0.28, 0.00; p-trend = 0.02). In participants with high thyroid antibody status, inverse associations between maternal initial serum TCDD and free T3 were significantly stronger than in participants with normal antibody status (p-interaction = 0.02). We also observed a positive association between maternal initial serum TCDD and TSH concentrations in participants with high thyroid antibody status (Q2: adj-β = 11.4%, 95%CI -25.2, 66.1; Q3: adj-β = 49.0%, 95%CI 3.0, 115.5; Q4: adj-β = 105.5, 95%CI 36.6, 209.2; p-trend < 0.01) but not in those participants with normal antibody status (p-interaction < 0.01). Similar results were found for TCDD estimated at pregnancy.
DISCUSSION
Our results suggest prenatal exposure to TCDD, a potent endocrine-disrupting compound, may alter thyroid function later in life. Populations with additional thyroid stress may be particularly susceptible to in utero exposure of thyroid disrupting chemicals.
Identifiants
pubmed: 32311913
pii: S0013-9351(20)30173-0
doi: 10.1016/j.envres.2020.109280
pmc: PMC7176740
mid: NIHMS1570798
pii:
doi:
Substances chimiques
Antibodies
0
Dioxins
0
Polychlorinated Dibenzodioxins
0
Thyroid Hormones
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
109280Subventions
Organisme : FIC NIH HHS
ID : F06 TW002075
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES007171
Pays : United States
Organisme : NIEHS NIH HHS
ID : F31 ES026488
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Ecotoxicol Environ Saf. 1980 Sep;4(3):298-320
pubmed: 7439100
Environ Health. 2016 Apr 26;15:55
pubmed: 27114094
Biochim Biophys Acta. 2003 Feb 17;1619(3):263-8
pubmed: 12573486
Hormones (Athens). 2010 Jan-Mar;9(1):28-40
pubmed: 20363719
Chemosphere. 2008 Feb;70(10):1865-72
pubmed: 17884136
Clin Chim Acta. 1989 Oct 16;184(3):219-26
pubmed: 2611996
Environ Health Perspect. 1993 Nov;101(6):504-8
pubmed: 8137779
Chemosphere. 2000 May-Jun;40(9-11):1247-53
pubmed: 10739069
Anal Chem. 1987 Aug 1;59(15):2000-5
pubmed: 3631519
Chemosphere. 2018 Mar;195:156-165
pubmed: 29268174
J Toxicol Sci. 2015 Jun;40(3):309-19
pubmed: 25972192
Environ Health Perspect. 2005 Nov;113(11):1645-50
pubmed: 16263525
Ann Epidemiol. 2003 May;13(5):335-43
pubmed: 12821272
Int J Obes (Lond). 2019 Nov;43(11):2233-2243
pubmed: 30659254
MMWR Morb Mortal Wkly Rep. 1988 Dec 9;37(48):733-6
pubmed: 2973556
Environ Int. 2018 Dec;121(Pt 1):71-84
pubmed: 30179766
J Clin Endocrinol Metab. 2013 Sep;98(9):3562-71
pubmed: 23824418
Chemosphere. 2008 Oct;73(7):1145-50
pubmed: 18790515
Int Arch Occup Environ Health. 2006 May;79(5):396-404
pubmed: 16217675
Lancet. 2012 Mar 24;379(9821):1142-54
pubmed: 22273398
Annu Rev Physiol. 2011;73:135-62
pubmed: 21054169
J Expo Sci Environ Epidemiol. 2014 Nov;24(6):588-94
pubmed: 24149975
Environ Health Perspect. 2004 Jan;112(1):22-7
pubmed: 14698926
Pediatr Res. 2010 Feb;67(2):205-10
pubmed: 20091939
J Toxicol Environ Health. 1989;27(2):165-71
pubmed: 2733058
J Autoimmun. 2009 May-Jun;32(3-4):231-9
pubmed: 19307103
Mutat Res. 2008 Jul-Aug;659(1-2):83-92
pubmed: 18093869
Eur J Endocrinol. 2006 May;154(5):599-611
pubmed: 16645005
Environ Health Perspect. 2009 Jul;117(7):1033-41
pubmed: 19654909
PLoS Med. 2008 Jul 29;5(7):e161
pubmed: 18666825
Arch Toxicol. 2005 May;79(5):260-7
pubmed: 15902423
Environ Health. 2012 Jun 28;11 Suppl 1:S10
pubmed: 22759492
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2508-2515
pubmed: 28472343
Food Chem Toxicol. 2011 Jun;49(6):1276-84
pubmed: 21414370
J Immunotoxicol. 2008 Oct;5(4):413-8
pubmed: 19404875
Environ Res. 2014 Aug;133:338-47
pubmed: 25019470
Toxicol Sci. 2006 Feb;89(2):408-14
pubmed: 16291828
Endocrinology. 2003 May;144(5):2075-83
pubmed: 12697716
Chemosphere. 1996 Oct;33(7):1317-26
pubmed: 8799996
Food Addit Contam. 2000 Apr;17(4):275-88
pubmed: 10912242
Pediatr Res. 1994 Oct;36(4):468-73
pubmed: 7816522
Endocr Rev. 2008 Feb;29(1):76-131
pubmed: 17991805
Environ Res. 2016 Jul;148:112-121
pubmed: 27038832
Toxicol Lett. 2004 Mar 1;147(2):133-42
pubmed: 14757317
Toxicol Sci. 2005 May;85(1):607-14
pubmed: 15716479
Toxicol Lett. 1995 Aug;78(3):253-62
pubmed: 7624895
Ann N Y Acad Sci. 2010 Jan;1183:25-37
pubmed: 20146706